Evidence map›Paper›PMID 32256178›Full record

ArticleSaudi journal of biological sciences2020

Cancer inhibition mechanism of lung cancer mouse model based on dye trace method.

Wei Zhang, Hongyan Shu, Lixin Fang, Ning Tang, Yucai Li, Bingrong Guo, Fanhui Meng

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wei ZhangDepartment of Thoracic Surgery, Linzi District People's Hospital, Zibo City 255400, China.
Hongyan ShuDepartment of Endocrinology, Linzi District People's Hospital, Zibo City 255400, China.
Lixin FangDepartment of Thoracic Surgery, Linzi District People's Hospital, Zibo City 255400, China.
Ning TangDepartment of Thoracic Surgery, Linzi District People's Hospital, Zibo City 255400, China.
Yucai LiDepartment of Thoracic Surgery, Linzi District People's Hospital, Zibo City 255400, China.
Bingrong GuoDepartment of Thoracic Surgery, Linzi District People's Hospital, Zibo City 255400, China.
Fanhui MengDepartment of Endocrinology, Linzi District People's Hospital, Zibo City 255400, China.
Linzi District People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To minimize the incidence and mortality of cancer, dye trace method was used to explore the mechanism of drug inhibition. 60 mice were selected as the research objects and randomly divided into five groups: model group, shikonin group, aconitine group, notoginsenoside R1 group, and compound group. When establishing the model, begin to administrate the medicine by gavage. The permeability of lung barrier was measured, and H.E staining, immunohistochemical staining, and Western blot test were carried out. The results showed that the mice in model group had decreased autonomic activity, increased permeability of the lung barrier, white nodules on the lung tissue, decreased protein expression related to cell proliferation and differentiation, and decreased protein expression associated with cell proliferation and differentiation, increased expression of related proteins in cancer stem cells, and low level of cell-linked communication. And the incidence of lung cancer in the model group mice was 100%. The histopathological changes in mice were improved to varying degrees after the intervention of the three drugs. Especially in the compound group, the incidence of lung cancer decreased to 8.3%. This study demonstrated that the combination of shikonin, aconitine and notoginsenoside R1 had a good anti-cancer effect, which provided a theoretical basis for clinical research.

Indexed as

Cancer inhibition mechanismDye tracer methodLung cancerMouse model

Identifiers

PMID32256178
PMCPMC7105657
OpenAlexW2998309293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.